Prestige Consumer Healthcare (PBH) Inventory (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Inventory of $163.6 million for Q4 2025, up 7.97% year-over-year from $151.5 million in Q4 2024, and up 2.89% quarter-over-quarter from $159.0 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Inventory (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Inventory history runs 15 years deep, the most recent figure standing at $163.6 million for Q4 2025.
- In Q4 2025, Inventory rose 7.97% year-over-year to $163.6 million; the TTM figure through Dec 2025 stood at $163.6 million (up 7.97% YoY), while the FY2025 annual figure was $147.7 million, up 6.48% from the prior year.
- Inventory for Q4 2025 stood at $163.6 million, up from $159.0 million in the prior quarter.
- The five-year high for Inventory was $169.8 million in Q2 2023, with the low at $105.5 million in Q2 2021.
- The 5-year median for Inventory is $150.1 million (2023), against an average of $142.6 million.
- The sharpest annual moves came in 2022 and 2024: Inventory jumped 49.16% in 2022, then retreated 14.44% in 2024.
- Prestige Consumer Healthcare's Inventory stood at $106.3 million in 2021, then surged by 49.16% to $158.5 million in 2022, then dropped by 6.24% to $148.6 million in 2023, then gained by 1.94% to $151.5 million in 2024, then advanced by 7.97% to $163.6 million in 2025.
- Business Quant data shows PBH's Inventory at $163.6 million in Q4 2025, $159.0 million in Q3 2025, and $153.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 816.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | 159.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159.13 Mn |
| Dec 31, 2025 | 163.59 Mn |
| Sep 30, 2025 | 159.00 Mn |
| Jun 30, 2025 | 153.13 Mn |
| Mar 31, 2025 | 147.71 Mn |
| Dec 31, 2024 | 151.52 Mn |
| Sep 30, 2024 | 156.23 Mn |
| Jun 30, 2024 | 152.04 Mn |
| Mar 31, 2024 | 138.72 Mn |
| Dec 31, 2023 | 148.64 Mn |
| Sep 30, 2023 | 161.28 Mn |
| Jun 30, 2023 | 169.85 Mn |
| Mar 31, 2023 | 162.12 Mn |
| Dec 31, 2022 | 158.52 Mn |
| Sep 30, 2022 | 140.51 Mn |
| Jun 30, 2022 | 133.77 Mn |
| Mar 31, 2022 | 120.34 Mn |
| Dec 31, 2021 | 106.27 Mn |
| Sep 30, 2021 | 107.92 Mn |
| Jun 30, 2021 | 105.55 Mn |